SE447113B - INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 2-AMINO-9- (2-HYDROXYETHOXIMETHYL) ADENINE AND 9- (2-HYDROXYETHOXIMETHYL) -GUANIN - Google Patents

INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 2-AMINO-9- (2-HYDROXYETHOXIMETHYL) ADENINE AND 9- (2-HYDROXYETHOXIMETHYL) -GUANIN

Info

Publication number
SE447113B
SE447113B SE8304549A SE8304549A SE447113B SE 447113 B SE447113 B SE 447113B SE 8304549 A SE8304549 A SE 8304549A SE 8304549 A SE8304549 A SE 8304549A SE 447113 B SE447113 B SE 447113B
Authority
SE
Sweden
Prior art keywords
mixture
hydroxyethoximethyl
give
acid
amino
Prior art date
Application number
SE8304549A
Other languages
Swedish (sv)
Other versions
SE8304549L (en
SE8304549D0 (en
Inventor
H J Schaeffer
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27109837&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE447113(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US05/773,135 external-priority patent/US4146715A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE8304549L publication Critical patent/SE8304549L/en
Publication of SE8304549D0 publication Critical patent/SE8304549D0/en
Publication of SE447113B publication Critical patent/SE447113B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems

Description

447 115 2 Enligt patentansökan 7709606-3 har man funnit att vissa 9-(2- -hydroxietoximetyl)derivat av puriner kan framställas via en ny och fördelaktig syntesväg. Den nämnda patentansökan 7709606-3 avser så- lunda ett förfarande för framställning av föreningar med formeln (I) (15 CH2.0.CH2.Ch2.0H vari R betecknar amino eller hydroxi; varvid en förening med formeln (II) 2 CHZOCHZCHZ-O-C-X 2-CXl och X1 och X2 är lika eller II O olika och vardera betecknar en lägre alkylgrupp, och R2 betecknar väte eller -Cxl under förutsättning att R2 betecknar väte då Rl be- H O tecknar hydroxi, hydrolyseras i närvaro av en bas. Alkylgruppen har företrädesvis l-4 kolatomer och helst är X1 och X identiska och betecknar var och en en metylgrupp. According to patent application 7709606-3, it has been found that certain 9- (2-hydroxyethoxymethyl) derivatives of purines can be prepared via a new and advantageous synthetic route. The said patent application 7709606-3 thus relates to a process for the preparation of compounds of formula (I) (CH2.0.CH2.Ch2.0H wherein R represents amino or hydroxy; wherein a compound of formula (II) 2 CHZOCHZCHZ- OCX 2 -CX1 and X1 and X2 are the same or II 0 different and each represents a lower alkyl group, and R2 represents hydrogen or -Cx1 provided that R2 represents hydrogen when R1 represents hydroxy, hydrolyzed in the presence of a base. preferably has 1-4 carbon atoms and most preferably X 1 and X are identical and each represents a methyl group.

Mellanprodukterna med formeln (II) är nya och föreliggande upp- finning åstadkommer, såsom mellanprodukter, föreningar med formeln (II) enligt ovan. Dessa föreningar kan framställas genom att man vari Rl betecknar hydroxi eller -NR bringar guanin eller 2-aminoadenin, vari 2- och 9-, respektive 2-, 6- och 9-ställningarna är acylerade, att reagera med en diester av 2~oxa-1,4-butandiol i närvaro av en katalytisk mängd av en stark syra, såsom svavelsyra, sulfonsyror såsom p-toluensulfonsyra, metan- sulfonsyra eller trifluormetansulfonsyra, sulfamsyra, bis-(p-nitro- fenyl)fosfat eller polyfosforsyra. s 447 115 Den acylerade purinen kan i sin tur framställas genom att man bringar att reagera motsvarande purin med en syraanhydrid, såsom ättiksyraanhydrid, eller annat acylerande medel, t ex syrahalogenid.The intermediates of formula (II) are novel and the present invention provides, as intermediates, compounds of formula (II) as above. These compounds can be prepared by reacting with guanine or 2-aminoadenine in which R1 represents hydroxy or -NR, wherein the 2- and 9-, respectively 2-, 6- and 9-positions are acylated, to react with a diester of 2-oxa -1,4-butanediol in the presence of a catalytic amount of a strong acid such as sulfuric acid, sulfonic acids such as p-toluenesulfonic acid, methanesulfonic acid or trifluoromethanesulfonic acid, sulfamic acid, bis- (p-nitrophenyl) phosphate or polyphosphoric acid. The acylated purine can in turn be prepared by reacting the corresponding purine with an acid anhydride, such as acetic anhydride, or other acylating agent, for example acid halide.

För framställning av diestern av 2-oxa-1,4-butandiol, bringas dioxolan att reagera med en syraanhydrid i närvaro av en katalytisk mängd av en stark syra, t ex en av dem som uppräknats ovan.To prepare the diester of 2-oxa-1,4-butanediol, dioxolane is reacted with an acid anhydride in the presence of a catalytic amount of a strong acid, for example one of those listed above.

Uppfinningen, vars kännetecken framgår av de efterföljan- de patentkraven, kommer nu att åskådliggöras med hänvisning till följande exempel, som belyser framställning av mellan- produkterna enligt uppfinningen och deras användning för fram- ställning av föreningar med formeln (I).The invention, the characteristics of which appear from the appended claims, will now be illustrated with reference to the following examples, which illustrate the preparation of the intermediates according to the invention and their use for the preparation of compounds of formula (I).

EXEMPEL l 9-(2-hydroxigtoximetyl)guanin En blandning av ättiksyraanhydrid (102 g), ättiksyra (15 g) och p-toluensulfonsyra (5,0 g), som kylts till l0°C försattes med dioxolan (70 g) under omröring och kylning i sådan utsträckning att temperaturen i reaktionskärlet aldrig översteg 40°C. Blandningen kyldes sedan till rumstemperatur och toluen (300 ml) och diacetyl- guäflin (50 g) tillsattes. Reaktionsblandningen uppvärmdes sedan till återloppskokning under omröring i 16 h. Den kyldes sedan till rumstemperatur, kloroform (50 ml) tillsattes och den fasta produkten avlägsnades genom filtrering. Filterkakan tvättades omsorgsfullt med kloroform och torkades för att ge 2-acetamido-9- *(2'äCetOXiet0Ximetyl)-hypoxantin. Den torkade filterkakan sattes till 40 % vattenhaltig metylamin (350 ml), och blandningen uppvärmdes till âterflödeskokning under omröring i 40 min, kyl- des och filtrerades. Filtratet indunstades under förminskat tryck till en uppslamning. Ubpslamningen kyldes och filtrerades, och filterkakan tvättades med etanol och torkades, varvid man erhöll 9-(2-hydroxietoximetyl)guanin (27 g, mer än 90 %-ig renhet) smp 255-257°C, utbyte = 56 %.EXAMPLE 1 9- (2-Hydroxyethoxymethyl) guanine A mixture of acetic anhydride (102 g), acetic acid (15 g) and p-toluenesulfonic acid (5.0 g), cooled to 10 ° C, was added with dioxolane (70 g) with stirring. and cooling to such an extent that the temperature in the reaction vessel never exceeded 40 ° C. The mixture was then cooled to room temperature and toluene (300 ml) and diacetylguane (50 g) were added. The reaction mixture was then heated to reflux with stirring for 16 hours. It was then cooled to room temperature, chloroform (50 ml) was added and the solid product was removed by filtration. The filter cake was washed thoroughly with chloroform and dried to give 2-acetamido-9- * (2'-CetOXietloxymethyl) -hypoxanthine. The dried filter cake was added to 40% aqueous methylamine (350 ml), and the mixture was heated to reflux with stirring for 40 minutes, cooled and filtered. The filtrate was evaporated under reduced pressure to a slurry. The slurry was cooled and filtered, and the filter cake was washed with ethanol and dried to give 9- (2-hydroxyethoxymethyl) guanine (27 g, greater than 90% purity) mp 255-257 ° C, yield = 56%.

EXEMEL 2 2: lZztrëzeëisteëiiflstzllssëaia En blandning av diacetylguanin (50 g), 2-oxa-l,4-butandiol- diacetat (59,8 g), och p-toluensulfonsyra (1,2 g) i toluen (350 ml) uppvärmdes under omröring till âterloppskokning i 16 h. Bland- ningen kyldes till rumstemperatur, filtrerades och filterkakan tvättades omsorgsfullt med toluen för att ge 2-acetamido-9~(2-acet_ oxletoximetyl)-hypoxantin. Filterkakan torkades och till- 447g11s 4 sattes till 40 % vattenhaltig metylamin (350 ml). Blandningen upp- värmdes under återloppskokning och omröring i 40min, kyldes till rumstemperatur och filtrerades. Filtratet indunstades under för- minskat tryck, varvid man erhöll en tjock uppslamning. Etanol (200 ml) tillsattes till uppslamningen, som sedan kyldes, filtre- rades, tvättades med etnaol och torkades, varvid man erhöll 9-(2-hydroxietoximetyl)guanin (36 g, mer än 90 %-ig renhet), utbyte = 75 %.EXAMPLE 2 2: Streets A mixture of diacetylguanine (50 g), 2-oxa-1,4-butanediol diacetate (59.8 g), and p-toluenesulfonic acid (1.2 g) in toluene (350 ml) was heated under stirring to reflux for 16 hours. The mixture was cooled to room temperature, filtered and the filter cake was washed thoroughly with toluene to give 2-acetamido-9 - (2-acetoxytoxymethyl) -hypoxanthine. The filter cake was dried and 447 g / l 4 was added to 40% aqueous methylamine (350 ml). The mixture was heated under reflux and stirring for 40 minutes, cooled to room temperature and filtered. The filtrate was evaporated under reduced pressure to give a thick slurry. Ethanol (200 ml) was added to the slurry, which was then cooled, filtered, washed with ethanol and dried to give 9- (2-hydroxyethoxymethyl) guanine (36 g, more than 90% purity), yield = 75 %.

EXEMEL 3 2:acetamido-9-(2-acetyloxietoximetyl)hypoxantin En blandning av diacetylguanin (1,0 g) 2-oxa-l,4-butandio1- diacetat (0,82 g) och p-toluensulfonsyra (23 mg) i mineralolja (4 g) uppvärmdes vid 1l5°C under omröring vid reducerat tryck över natten. Mineraloljan avdekanterades. Återstoden triturera- des med kloroform och extraherades med kokande metanol. Metanol- extraktet koncentrerades till 50 ml, kyldes och filtrerades.EXAMPLE 3 2: Acetamido-9- (2-acetyloxyethoxymethyl) hypoxanthine A mixture of diacetylguanine (1.0 g) 2-oxa-1,4-butanediol-diacetate (0.82 g) and p-toluenesulfonic acid (23 mg) in mineral oil (4 g) was heated at 115 ° C with stirring under reduced pressure overnight. The mineral oil was decanted. The residue was triturated with chloroform and extracted with boiling methanol. The methanol extract was concentrated to 50 ml, cooled and filtered.

Filtratet indunstades till torrhet, varvid man erhöll en fast återstod (0,43 g). Den fasta återstoden renades med kolonnkroma- tografi (silikagel, 10 g, i kloroform, eluerad med 1:1 kloro- form:aceton), varefter följde omkristallisation ur etanol varvid man erhöll 2-acetamido-9-(2-acetyloxietoximetyl)hypoxantin (o,14 g), smp 2o2,s-2o4,5°c.The filtrate was evaporated to dryness to give a solid residue (0.43 g). The solid residue was purified by column chromatography (silica gel, 10 g, in chloroform, eluting with 1: 1 chloroform: acetone), followed by recrystallization from ethanol to give 2-acetamido-9- (2-acetyloxyethoxymethyl) hypoxanthine ( o, 14 g), mp 2o2, s-2o4,5 ° c.

EXEMPEL 4 2:amino-9-(2-hydrogietoximetyl)adenin (a) 2-formamidoadenin (89,0 g) placerades i en 5 liters flaska utrustad med luftomrörare och återloppskylare (CaCl2- -torkrör), till vilket man satte ättiksyraanhydrid (4 liter).EXAMPLE 4 2: Amino-9- (2-hydrogietoxymethyl) adenine (a) 2-formamidoadenine (89.0 g) was placed in a 5 liter flask equipped with an air stirrer and reflux condenser (CaCl 2 - drying tube), to which was added acetic anhydride ( 4 liters).

Blandningen fick återloppskoka i 60 h. Vid slutet av denna tids- period avlägsnades anhydridöverskottet genom destillation vid atmosfärstryck tills ungefär 3,5 liter destillat erhållits.The mixture was refluxed for 60 hours. At the end of this time, the excess anhydride was removed by distillation at atmospheric pressure until about 3.5 liters of distillate were obtained.

Destillationen fortsattes under förminskat tryck för avlägsnan- de av större delen av kvarvarande anhydrid. En mörkbrun återstod i reaktionskärlet blev en viskös gummiartad massa vid kylning till rumstemperatur och denna massa upplöstes sedan i diklormetan, filtrerades för avlägsnande av suspenderat fast material, och lösningsmedlet avlägsnades i vakuum, varvid man erhöll 211,0 g (* 100 %) 2,6-bis-(diacetylamino)-9-acetylpurin. Det analyserade utbyte var 96,7 % baserat på NMR och resten av materialet ut- gjordes av ättiksyraanhydrid. 5 447 113 (b) Penta-acetylpurin (174 g) förenades med 1,4-diacetoxi- -2-oxabutan (l26,8 g) i en flaska, som var utrustad med luft- omröring och torkrör. Blandningen placerades sedan i ett olje- bad vid l30°C ochcxmürdes under några få minuter för homogenisering av satsen. Syrakatalysatorn, paratoluensulfonsyran (2,74 g), tillsattes sedan i en portion och uppvärmningen fortsattes i vakuum under 4 h, under vilken tidsperiod en nästan kvantitativ omvandling till produkter observerades. Reaktionsblandningen kyl- des sedan till rumstemperatur ochden lagrades i torr kvävgas. (c) Fusionsprodukten (208,5 g) löstes i etanol (5 ml/g) vid rumstemperatur och överfördes tillen fuska, som var utrustad med dropptratt, luftomröring och termometer. n-butylamin (l40,4 g) tillsattes sedan droppvis under en period på 2 h och den exoterma reaktionen nxfleflfibsneíhjälp av ettvattenbad. Den högsta tempera- tur, som reaktionsblandningen fick anta var endast 30°C. Produkten började skiljas från reaktionsblandningen under additionsförlop- pet. Efter fullbordad tillsatsomrördes blandningen vid rums- temperatur i 3 h varefter den placerades i kallt rum över natten.Distillation was continued under reduced pressure to remove most of the remaining anhydride. A dark brown residue in the reaction vessel became a viscous gummy mass on cooling to room temperature and this mass was then dissolved in dichloromethane, filtered to remove suspended solids, and the solvent removed in vacuo to give 211.0 g (* 100%) 2. 6-bis- (diacetylamino) -9-acetylpurine. The analyzed yield was 96.7% based on NMR and the rest of the material was acetic anhydride. 5,447,113 (b) Pentaacetylpurine (174 g) was combined with 1,4-diacetoxy-2-oxabutane (26.8 g) in a flask equipped with air agitator and drying tube. The mixture was then placed in an oil bath at 130 ° C and stirred for a few minutes to homogenize the batch. The acid catalyst, the paratoluenesulfonic acid (2.74 g), was then added in one portion and heating was continued in vacuo for 4 hours, during which time an almost quantitative conversion to products was observed. The reaction mixture was then cooled to room temperature and stored in dry nitrogen. (c) The fusion product (208.5 g) was dissolved in ethanol (5 ml / g) at room temperature and transferred to a cheat equipped with a dropping funnel, air stirrer and thermometer. n-Butylamine (140.4 g) was then added dropwise over a period of 2 hours and the exothermic reaction nx fl e flfi bsneí help of a water bath. The highest temperature that the reaction mixture was allowed to assume was only 30 ° C. The product began to separate from the reaction mixture during the addition process. After completion of the addition, the mixture was stirred at room temperature for 3 hours, after which it was placed in a cold room overnight.

Produkten avlägsnades genom filtrering, varvid man erhöll en pasta- liknande massa, som uppslammades med aceton 1 x 500 ml) och om- filtrerades. Denna massa torkades i vakuum vid 65°C i 3 h och sedan vid rumstemperatur över natten, varvid man erhöll l54,2 g (9l,7 %) av en ljusbrun hård susbstans. Produkten renades genom att man löste den i het dimetylformamid (lO ml/g) vid 100-llO°C för bild- ning av en opakbrun lösning. Efter kylning över natten vid 5°C avlägsnades produkten genom filtrering, tvättades med aceton (l x 250 ml) och lufttorkades, varvid man erhöll 121,7 g (78,8 %) 2,6-diacetamido-9-(2-acetoxietoximetyl)purin. (d) 2,6-diacetamido-9-(2-acetoxietoximetyl)purin (121,7 g) tillsattes till en omrörd lösning av vattenhaltig metylamin (608,5 ml av 40 % lösning) under en 5 min period. Tillsatsen åtföljdes av en svagt exotermisk reaktion, som höjde blandningens temperaturtill35¶3od~allt fast material upplöstes på några få minuter. Efter omröring i 2 l/2 h visade tunnskiktskromatografi av blandningen att reaktionen var fullbordad. Blandningen koncen- trerades sedan i vakuum på vattenbad vid 45-5000, varvid man er- höll tjock massa av bruna kristaller. Denna massa uppslammades sedan med aceton (545 ml, 7 ml/g) i l5 min för avlägsnande av 447 113 6 N-metylacetamid och vakuumfiltrerades. Kakan sköljdes me (1 x 200 ml) och lufttorkades, varvid man erhöll 74,7 g oren, hydratiserad 2-amino-9-(2-hydroxietoximetyl)adenin ljusbruna kristaller. Dessa torkades i vakuum vid 80°C i varvid man erhöll 69,3 g (89,0 %) torr produkt.The product was removed by filtration to give a paste-like mass which was slurried with acetone (1 x 500 ml) and re-filtered. This mass was dried in vacuo at 65 ° C for 3 hours and then at room temperature overnight to give 155.2 g (91, 7%) of a light brown hard substance. The product was purified by dissolving it in hot dimethylformamide (10 ml / g) at 100-110 ° C to give an opaque brown solution. After cooling overnight at 5 ° C, the product was removed by filtration, washed with acetone (1 x 250 ml) and air dried to give 121.7 g (78.8%) of 2,6-diacetamido-9- (2-acetoxyethoxymethyl). purin. (d) 2,6-Diacetamido-9- (2-acetoxyethoxymethyl) purine (121.7 g) was added to a stirred solution of aqueous methylamine (608.5 ml of 40% solution) over a 5 minute period. The addition was accompanied by a slight exothermic reaction which raised the temperature of the mixture to 35 ° C and all solids dissolved in a few minutes. After stirring for 2 l / 2 h, thin layer chromatography of the mixture showed that the reaction was complete. The mixture was then concentrated in vacuo on a water bath at 45-5000 to give a thick mass of brown crystals. This mass was then slurried with acetone (545 ml, 7 ml / g) for 15 minutes to remove 447,113 N-methylacetamide and vacuum filtered. The cake was rinsed with (1 x 200 ml) and air dried to give 74.7 g of crude, hydrated 2-amino-9- (2-hydroxyethoxymethyl) adenine light brown crystals. These were dried in vacuo at 80 ° C to give 69.3 g (89.0%) of dry product.

EXEMPEL 5 6,19 g 2-acetamido-9-(2-acetyloxietoximetyl)hypoxantin suspen- derades i 40 ml natriumhydroxid och uppvärmdes under återflöde i 1 h. Blandningen kyldes, neutraliserades med 6N klorvätesyra och produkten filtreraåes av-Fastämnet tvättades med 10 ml isvatten och med 15 ml aceton och torkades över natten under vakuum. 4,13 g (9l,8%) 9-(2-hydroxietoxïmetyl)guanin erhölls, smältpunkt 255-257°c; EXEMPEL 6 6,19 g 2-acetamido-9-(2-acetyloxietoximetyl)hypoxantin upp- slammades i en lösning av 3,24 g natriummetylat i 40 ml metanol.EXAMPLE 5 6.19 g of 2-acetamido-9- (2-acetyloxyethoxymethyl) hypoxanthine was suspended in 40 ml of sodium hydroxide and heated under reflux for 1 hour. The mixture was cooled, neutralized with 6N hydrochloric acid and the product was filtered off. The solid was washed with 10 ml. ice water and with 15 ml of acetone and dried overnight under vacuum. 4.13 g (91, 8%) of 9- (2-hydroxyethoxymethyl) guanine were obtained, m.p. 255-257 ° C; EXAMPLE 6 6.19 g of 2-acetamido-9- (2-acetyloxyethoxymethyl) hypoxanthine were slurried in a solution of 3.24 g of sodium methylate in 40 ml of methanol.

Bladningen uppvärmdes under återflöde i 1 h och fick svalna. 3,96 g isättika tillsattes och blandningen hälldes i 40 ml vatten.The mixture was heated under reflux for 1 hour and allowed to cool. 3.96 g of glacial acetic acid were added and the mixture was poured into 40 ml of water.

Efter kylning, OOC, filtrerades den resulterande fällningen, tvät- tades med 15 ml kallt vatten och med 15 ml aceton och torkades under vakuum, vilket gav 4,03 g (89,6%) 9-(2-hydroxietoximetyl)- guanin, smältpunkt 255-25700.After cooling, 0 ° C, the resulting precipitate was filtered, washed with 15 ml of cold water and with 15 ml of acetone and dried under vacuum to give 4.03 g (89.6%) of 9- (2-hydroxyethoxymethyl) guanine. melting point 255-25700.

EXEMPEL 7 6,19 g 2-acetamido~9-(2-acetyloxietoximetyl)hypoxantin sattes till en lösning av 3,96 g kaliumhydroxid i 40 ml etanol och upp- värmdes under återflöde i l h. Blandningen fick svalna och 3,96 g isättika tillsattes. Bladningen hälldes i 40 ml vatten och 50 ml vatten tillsattes. pH-värdet justerades till 7,0 med vattenhaltig natriumhydroxid och blandningen kyldes med isvatten och filtrera- des. Fastämnet tvättades med 20 ml kallt vatten och med 20 ml aceton och torkades under vakuum för att ge 4,0 g (88,9%) 9-(2-hydroxietoximetyl)guanin, smältpunkt 255-257°C.EXAMPLE 7 6.19 g of 2-acetamido-9- (2-acetyloxyethoxymethyl) hypoxanthine was added to a solution of 3.96 g of potassium hydroxide in 40 ml of ethanol and heated under reflux for 1 hour. The mixture was allowed to cool and 3.96 g of glacial acetic acid was added. The mixture was poured into 40 ml of water and 50 ml of water was added. The pH was adjusted to 7.0 with aqueous sodium hydroxide and the mixture was cooled with ice water and filtered. The solid was washed with 20 ml of cold water and with 20 ml of acetone and dried under vacuum to give 4.0 g (88.9%) of 9- (2-hydroxyethoxymethyl) guanine, m.p. 255-257 ° C.

EXEMPEL 8» 6,19 g 2-acetamido-9-(2-acetyloxietoximetyl)hypoxantin upp- slammades med 5 mg trietylamin och 40 ml vatten och blandningen uppvärmdes under återflöde i 2 h. Blandningen fick svalna till OOC och filtrerades. Fastämnet tvättades med 15 ml vatten och med 15 ml aceton och torkades under vakuum, vilket gav 4,34 g (96%) 9-(2-hydroxietoximetyl)guanin, smältpunkt 255-257°C.EXAMPLE 8 6.19 g of 2-acetamido-9- (2-acetyloxyethoxymethyl) hypoxanthine were slurried with 5 mg of triethylamine and 40 ml of water and the mixture was heated under reflux for 2 hours. The mixture was allowed to cool to 0 ° C and filtered. The solid was washed with 15 ml of water and with 15 ml of acetone and dried under vacuum to give 4.34 g (96%) of 9- (2-hydroxyethoxymethyl) guanine, m.p. 255-257 ° C.

Claims (2)

1. 7 447 115 PATENTKRAV l. Mellanprodukter för användning vid förfarande för framställ- ning av föreningar med formeln (I) R N i N/ \ . \ Å I (I) HZN N lll cnrdcnrcnz .oH vari R betecknar amino eller hydroxi, k ä n n e t e c k n a d e av att de utgöres av föreningar med formeln (II) 1 2 N\ i ' (ï | cm . \_ , xl-(Iz-NRZ \N/ ”i 3 cn.o.cn.crg.oc.xz 2 vari Rl betecknar hydroxi eller -NR2-C-X1, och X1 och X2 är lika 8 eller olika och betecknar vardera en lägre alkylgrupp, och R2 betecknar väte eller -CXl, varvid R2 betecknar väte, då Rl be- ö' tecknar hydroxi.1. Intermediate claims 1. Intermediates for use in the process for the preparation of compounds of formula (I) R N in N / \. Wherein R represents amino or hydroxy, characterized in that they are compounds of the formula (II) 1 2 N \ i '(ï | cm. \ _, Xl- ( Wherein R 1 represents hydroxy or -NR 2 -C-X 1, and X 1 and X 2 are the same 8 or different and each represents a lower alkyl group, and R2 represents hydrogen or -CX1, where R2 represents hydrogen, when R1 represents hydroxy. 2. Mellanprodukter enligt krav l, k ä n n e t e c k n a d e av att X1 och X2 är desamma och vardera betecknar en metylgrupp.Intermediates according to Claim 1, characterized in that X 1 and X 2 are the same and each represents a methyl group.
SE8304549A 1976-08-27 1983-08-23 INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 2-AMINO-9- (2-HYDROXYETHOXIMETHYL) ADENINE AND 9- (2-HYDROXYETHOXIMETHYL) -GUANIN SE447113B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71810576A 1976-08-27 1976-08-27
US05/773,135 US4146715A (en) 1975-08-27 1977-02-28 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines

Publications (3)

Publication Number Publication Date
SE8304549L SE8304549L (en) 1983-08-23
SE8304549D0 SE8304549D0 (en) 1983-08-23
SE447113B true SE447113B (en) 1986-10-27

Family

ID=27109837

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7709606A SE432764B (en) 1976-08-27 1977-08-26 PROCEDURE FOR PREPARING 2-AMINO-9- (2-HYDROXYETOXIMETHYL) ADENIN AND 9- (2-HYDROXYTOXYMETHYL) GUANINE
SE8304549A SE447113B (en) 1976-08-27 1983-08-23 INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 2-AMINO-9- (2-HYDROXYETHOXIMETHYL) ADENINE AND 9- (2-HYDROXYETHOXIMETHYL) -GUANIN

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7709606A SE432764B (en) 1976-08-27 1977-08-26 PROCEDURE FOR PREPARING 2-AMINO-9- (2-HYDROXYETOXIMETHYL) ADENIN AND 9- (2-HYDROXYTOXYMETHYL) GUANINE

Country Status (12)

Country Link
AT (1) AT357566B (en)
CA (2) CA1096863A (en)
CH (1) CH634843A5 (en)
CS (1) CS196384B2 (en)
DD (1) DD131856A6 (en)
DK (1) DK147857C (en)
FI (1) FI64160C (en)
GB (1) GB1567671A (en)
NL (1) NL7709458A (en)
NO (2) NO147186C (en)
SE (2) SE432764B (en)
YU (1) YU41079B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
US4918219A (en) * 1983-10-31 1990-04-17 Warner-Lambert Company Glycerine derivatives
YU45690B (en) * 1984-12-22 1992-07-20 Krka Tovarna Zdraviln.Sol.O. PROCEDURE FOR PREPARING 9- (2-HYDROXYETHOXYMETHYL) -GUANINE
EP0564006A3 (en) * 1987-05-04 1993-12-15 Krka Tovarna Zdravil Process for preparing purine derivatives and novel purine derivatives
US5756737A (en) * 1993-09-10 1998-05-26 Recordati S.A. Chemical And Pharmaceutical Company Process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine
DE19536164A1 (en) * 1995-09-28 1997-04-03 Boehringer Ingelheim Kg Improved Process for the Production of 9 - [(2-Hydroxyethoxy) methyl] guanine (Acyclovir)
IT1276126B1 (en) * 1995-11-14 1997-10-27 Archimica Spa PROCEDURE FOR THE PREPARATION OF 9 - ((2-HYDROXYETHOXY) METHYL) GUANINE
WO1997024357A1 (en) * 1995-12-28 1997-07-10 Mallinckrodt Chemical, Inc. Process for synthesis and purification of a compound useful in the preparation of acyclovir

Also Published As

Publication number Publication date
GB1567671A (en) 1980-05-21
SE432764B (en) 1984-04-16
YU41079B (en) 1986-12-31
NO147186B (en) 1982-11-08
DK380377A (en) 1978-02-28
CS196384B2 (en) 1980-03-31
NO150119C (en) 1984-08-22
ATA620177A (en) 1979-12-15
NO772959L (en) 1978-02-28
DD131856A6 (en) 1978-07-26
YU202277A (en) 1983-02-28
DK147857B (en) 1984-12-24
CH634843A5 (en) 1983-02-28
NO822502L (en) 1978-02-28
CA1096863A (en) 1981-03-03
FI772548A (en) 1978-02-28
NL7709458A (en) 1978-03-01
NO150119B (en) 1984-05-14
SE8304549L (en) 1983-08-23
SE7709606L (en) 1978-02-28
NO147186C (en) 1983-02-16
SE8304549D0 (en) 1983-08-23
CA1096864A (en) 1981-03-03
FI64160B (en) 1983-06-30
FI64160C (en) 1983-10-10
AT357566B (en) 1980-07-25
DK147857C (en) 1985-06-10

Similar Documents

Publication Publication Date Title
Speer et al. Some alkyl homologs of theophylline
SE447113B (en) INTERMEDIATE PRODUCTS FOR THE PREPARATION OF 2-AMINO-9- (2-HYDROXYETHOXIMETHYL) ADENINE AND 9- (2-HYDROXYETHOXIMETHYL) -GUANIN
KR100218610B1 (en) Preparation of n-9 substituted guanine compounds
Yamazaki et al. Synthesis of inosine, 2-alkylinosine, and xanthosine from 5-amino-1-. beta.-D-ribofuranosyl-4-imidazolecarboxamide
CA1187874A (en) Preparation of 1-substituted-2-amino-benzimidazoles
US3872082A (en) Substituted purineribofuranoside-3,5-cyclophosphate compounds and process for their preparation
JPH0714937B2 (en) Glyoxal-N2-guanine adduct and process for producing the same
Tronchet et al. Chemistry and pharmacology of apoise. 7. Susceptibility of some branched-chain sugar nucleosides to enzymic deamination
US3029239A (en) Basic substituted 1-and 7-alkylxanthines or salts thereof
Zecchini et al. A new route to N2‐and N3‐substituted‐2, 3‐diaminopyridines. Synthesis of 1‐and 3‐alkoxycarbonyl‐v‐triazolo [4, 5‐b] pyridines
Joshi et al. Benzoquinone derivatives. Part I. Reactions of primary aliphatic amines with embelin (2, 5-dihydroxy-3-undecyl-1, 4-benzoquinone) and di-o-methylembelin
CA1285936C (en) 3-acylamino-3-deoxyallose derivatives
JPS633875B2 (en)
CA1296001C (en) 1-hydroxyalkylxanthines, processes for their preparation and medicaments containing them
JPS5859959A (en) Aminosulfonic acid, its preparation and catalyst
Kokel The reaction of N, N‐dimethyldichloromethyleniminium chloride (phosgeniminium chloride) with 6‐N‐arylaminouracils. A new and convenient “one pot” synthesis of l, 3‐dimethyl‐5‐dimethylaminopyrimido [4, 5‐b] quinoline‐(1H, 3H)‐2, 4‐diones, 1, 3‐dimethyl‐5‐chloropyrimido [4, 5‐b] quinoline‐(1H, 3H)‐2, 4‐diones and 3‐methyl‐10‐alkyl‐5‐chloropyrimido [4, 5‐b] quinoline‐(3H, 10H)‐2, 4‐diones (3‐methyl‐10‐alkyl‐5‐chloro‐5‐deazaflavins)
SU932991A3 (en) Process for producing purine derivatives
SE457260B (en) INTERMEDIATE FOR THE PREPARATION OF 2-METHYL ERGOPEPTINES AND SETTLE TO MANUFACTURE THE INTERMEDIATE PRODUCT
US2784188A (en) Synthesis of 4, 5-diamino-6-dimethylamino pyrimidine
US2557721A (en) 9, 10-dihydropteridines and process of preparing same
CA1089854A (en) Pyrazolo[1,5-a]pyrido[4,3-d]pyrimidin-9(4h)- one and derivatives thereof
Gueiffier et al. Conversion of imidazo [1, 2-a] pyridines into pyrido [1, 2-e] purines
PL108512B1 (en) Method of producing purine derivatives
US5338741A (en) 1-hydroxyalkylxanthines and medicaments containing them
JPS5946511B2 (en) 1-(N-hydroxyalkylcarbamoyl)-5-fluorouracils and their production method

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8304549-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8304549-2

Format of ref document f/p: F